Stand Up To Cancer
Stand Up To Cancer accelerates cancer treatment innovations by funding collaborative research, leading to nine new FDA-approved treatments and focusing on underserved communities.
Services
Stand Up To Cancer funds and develops the newest and most promising cancer treatments to help patients. The organization focuses on dramatically accelerating the rate of new discoveries by connecting top scientists in unprecedented collaborations. This approach aims to create breakthroughs that lead to better cancer prevention, diagnosis, and treatment. The goal is to save lives now by supporting and driving innovative research.
Research Collaborations
Stand Up To Cancer's innovative funding model mandates collaboration among researchers. This approach includes a network of more than 3,000 scientists working across more than 210 institutions. This collaborative effort is designed to accelerate cancer research breakthroughs, bringing together diverse expertise to tackle complex cancer challenges. As of now, the research portfolio includes 130 collaborative research teams, showcasing the organization's commitment to joint scientific endeavors.
FDA-Approved Treatments
Stand Up To Cancer-supported research has led to 9 new FDA-approved cancer treatments. These treatments are a direct result of the organization's strategy to fund and drive cutting-edge research. By prioritizing innovation and collaboration, Stand Up To Cancer contributes significantly to developing effective cancer therapies that improve patient outcomes.
Support for Medically Underserved Communities
Since January 2020, Stand Up To Cancer has required all grant proposals to address the recruitment and retention of patients from medically underserved communities. This initiative ensures that research efforts are inclusive and that advancements in cancer treatment reach broader and more diverse populations. Stand Up To Cancer's focus on equitable access to clinical trials and treatments supports its mission to save lives and improve health outcomes for all patients.
Early-Career Investigator Programs
Stand Up To Cancer supports 93 individual early-career investigators as part of its research portfolio. This investment in emerging scientific talent ensures a continuous pipeline of innovative research. By nurturing the next generation of scientists, the organization strengthens its long-term impact on cancer research and treatment advancements.